Voloridge Investment Management’s Alpine Immune Sciences Inc ALPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-267,232
Closed -$10.6M 1407
2024
Q1
$10.6M Buy
267,232
+33,482
+14% +$988K 0.04% 478
2023
Q4
$4.46M Buy
+233,750
New +$3.25M 0.02% 649

Voloridge Investment Management's ALPN Position: Q2 2024 in Review

Voloridge Investment Management sold out of Alpine Immune Sciences Inc (ALPN) in Q2 2024, closing a stake of 267,232 shares — an estimated $10.6M sold.

Voloridge Investment Management first reported a position in ALPN in Q4 2023 and held it in 2 quarters. The position peaked at $10.6M in Q1 2024. 0 funds tracked by Wall St. Rank hold ALPN as of Q2 2024.

  • Voloridge Investment Management reported no remaining Alpine Immune Sciences Inc position as of Q2 2024 after selling out during the quarter.
  • Voloridge Investment Management sold 267,232 Alpine Immune Sciences Inc shares in Q2 2024, an estimated $10.6M.
  • Voloridge Investment Management first reported a position in Alpine Immune Sciences Inc in Q4 2023 and held it in 2 quarters.
  • Voloridge Investment Management's Alpine Immune Sciences Inc position peaked at $10.6M in Q1 2024.
  • 0 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q2 2024.

Based on Voloridge Investment Management's 13F filing for Q2 2024, filed 14 Aug 2024.